Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
Clinical trial NCT05673187 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05673187
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2025-07-28
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.